Secondary carcinogenesis in patients treated with radiation: A review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects

Radiation Research

Volumn 167, Issue 1, 2007, Pages 12-42

  Suit, Herman ^a   Goldberg, Saveli ^a   Niemierko, Andrzej ^a   Ancukiewicz, Marek ^a   Hall, Eric ^b   Goitein, Michael ^a   Wong, Winifred ^a   Paganetti, Harald ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMIC BOMB SURVIVOR; BLADDER CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CELL TRANSFORMATION; DOG; GENDER; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IN VITRO STUDY; KIDNEY CANCER; MACACA; MALIGNANT NEOPLASTIC DISEASE; MAMMAL CELL; MOUSE STRAIN; NONHUMAN; OCCUPATIONAL EXPOSURE; PANCREAS CANCER; PRIMATE; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION EXPOSURE; RADIATION HAZARD; RECTUM CANCER; REVIEW; RODENT; SEX DIFFERENCE; SPECIES COMPARISON; SPECIES DIFFERENCE; STOMACH CANCER; STRAIN DIFFERENCE;

ANIMALS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HAPLORHINI; HUMANS; MACACA MULATTA; MALE; MICE; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WARFARE; OCCUPATIONAL EXPOSURE; PRIMATES; RISK; RISK FACTORS;

CANIS FAMILIARIS; MACACA MULATTA; MAMMALIA; MUS; PRIMATES; RODENTIA;

EID: 33846190671     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR0527.1     Document Type: Review

References (112)

1. P. Brown, American Martyrs to Science Through the Roentgen Rays. Charles C. Thomas, Springfield, IL, 1936.
2. C. Besk, Roentgen Ray Diagnosis and Therapy. Appleton and Lange, New York, 1904.
3. P. Wichmann, Radium in der Heilkuinde. Leopold Voss, Hamburg, 1911.
4. E. J. Hall and A. J. Giaccia, Radiobiology for the Radiologist, 6th ed. Lippincott, Williams and Wilkins, Philadelphia, 2006.
5. D. Preston, D. Pierce, Y. Shimizu, H. Cullings, S. Fujita, S. Funamoto and K. Kodama, Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat. Res. 162, 377-389 (2004).
6. D. Preston, Y. Shimizu, D. Pierce, A. Suyama and K. Mabuchi, Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat. Res. 160, 381-407 (2003).
7. D. Pierce, Y. Shimizu, D. Preston, M. Vaeth and K. Mabuchi, Studies of the mortality of atomic bomb survivors. Report 12, Part 1. Cancer: 1950-1990. Radiat. Res. 146, 1-27 (1996).
8. UNSCEAR, Sources and Effects of Ionizing Radiation, Vol. II, Effects, Annex II. United Nations, New York, 2000.
9. J. Boice, H. Storm, R. Curtis, O. Jensen, R. Kleinerman, H. Jensen, J. Flannery and J. Fraumeni, Multiple Primary Tumors in Connecticut and Denmark. Publication 85-2714, National Institutes of Health, Bethesda, MD, 1985.
10. D. Katz, J. Baptista, S. Azen and M. Pike, Obtaining confidence intervals for the risk ratio in cohort studies. Biometrics 34, 469-474 (1978).
11. A. Whitehead, Meta-Analysis of Controlled Clinical Trials. Wiley, New York, 2002.
12. E. Demidenko, Mixed Effects Models. Theory and Applications. Wiley, New York, 2004.
13. J. Maindonald and J. Braun, Data Analysis and Graphics Using R. Cambridge University Press, Cambridge, 2003.
14. C. Borek and E. Hall, Transformation of mammalian cells in vitro by low doses of X rays. Nature 243, 450-453 (1973).
15. A. Han and M. Elkind, Transformation of mouse C3H/10T1/2 cells by single and fractionated doses of X-rays and fission-spectrum neutrons. Cancer Res. 39, 123-130 (1979).
16. 60Co gamma rays. Cancer Res. 40, 3328-3332 (1980).
17. 2 mouse cells. Radiat. Res. 117, 114-127 (1989).
18. G. S. Heyes and A. Mill, The neoplastic transformation potential of mammography X-rays and atomic bomb spectrum radiation. Radiat. Res. 162, 120-127 (2004).
19. M for various end points. Radiat. Res. 157, 99-105 (2002).
20. S. Ko, X. Liao, S. Molloi, E. Elmore and J. L. Redpath, Neoplastic transformation in vitro after exposure to low doses of mammographic-energy X rays: Quantitative and mechanistic aspects. Radiat. Res. 162, 646-654 (2004).
21. J. L. Redpath, Q. Lu, X. Lao, S. Molloi and E. Elmore, Low doses of diagnostic energy X-rays protect against neoplastic transformation in vitro. Int. J. Radiat. Biol. 79, 235-240 (2003).
22. 2 cells. Radiat. Res. 146, 369-373 (1996).
23. S. Sawant, G. Randers-Pehrson, C. Geard, D. Brenner and E. Hall, The bystander effect in radiation oncogenesis. I. Transformation in C3H 10T1/2 cells in vitro can be initiated in the unirradiated neighbors of irradiated cells. Radiat. Res. 155, 397-401 (2001).
24. J. Storer, T. Mitchell and R. J. M. Fry, Extrapolation of the relative risk of radiogenic neoplasms across mouse strains and to man. Radiat. Res. 114, 331-353 (1988).
25. R. Ullrich, M. Jernigan, G. Cosgrove, L. Satterfield, N. Bowles and J. Storer, The influence of dose and dose rate on the incidence of neoplastic disease in RFM mice after neutron irradiation. Radiat. Res. 68, 115-131 (1976).
26. R. L. Ullrich and R. J. Preston, Myeloid leukemia in male RFM mice following irradiation with fission spectrum neutrons or γ rays. Radiat. Res. 109, 165-170 (1987).
27. J. Thomson, F. Williamson and D. Grahn, Life shortening in mice exposed to fission neutrons and γ rays. V. Further studies with single low doses. Radiat. Res. 104, 420-428 (1985).
28. V. Covelli, V. DiMajo, M. Coppola and S. Rebessi, The dose-response relationships for myeloid leukemia and malignant lymphoma in BC3F mice. Radiat. Res. 119, 553-561 (1989).
29. V. DiMajo, M. Coppola, S. Rebessi, B. Bassani, T. Alati, A. Saran, C. Bangrazi and V. Covelli, Radiation-induced mouse liver neoplasms and hepatocyte survival. J. Natl. Cancer Inst. 77, 933-939 (1986).
30. V. DiMajo, S. Rebessi, S. Pazzaglia, A. Saran and V. Covelli, Carcinogenesis in laboratory mice after low doses of ionizing radiation. Radiat. Res. 159, 102-108 (2003).
31. J. Maisin, A. Wambersie, G. Gerber, G. Mattelin, M. Lambiet-Collier, B. DeCoster and J. Gueulette, Life-shortening and disease incidence in C57B1 mice after single and fractionated γ and high energy neutron exposure. Radiat. Res. 113, 300-317 (1988).
32. J. Maisin, G. Gerber, J. Vankerkom and A. Wambersie, Survival and diseases in C57BL mice exposed to X rays or 3.1 MeV neutrons at an age of 7 or 21 days. Radiat. Res. 146, 453-460 (1996).
33. J. Maisin, A. Wambersie, G. Gerber, G. Mattelin, M. Lambiet-Collier, B. DeCoster and J. Gueulette, Life-shortening and disease incidence in mice after exposure to γ rays or high-energy neutrons. Radiat. Res. 128 (Suppl.), S117-S123 (1991).
34. S. Sasaki and N. Fukuda, Dose-response relationship for induction of solid tumors in female B6C3F1 mice irradiated neonatally with a single dose of gamma rays. J. Radiat. Res. 40, 229-241 (1999).
35. H. D. Suit, R. Sedlacek, L. Fagundes, M. Goitein and K. Rothman, Time distribution of recurrences of immunogenic and non-immunogenic tumor following local irradiation. Radiat. Res. 73, 251-266 (1978).
36. J. Thomson, F. Williamson, D. Grahn and E. J. Ainsworth, Life shortening in mice exposed to fission neutrons and γ rays. I. Single and short-term fractionated exposures. Radiat. Res. 86, 559-572 (1981).
37. J. Thomson, F. Williamson, D. Grahn and E. J. Ainsworth, Life shortening in mice exposed to fission neutrons and γ rays. II. Duration-of-life and long-term fractionated exposures. Radiat. Res. 86, 573-579 (1981).
38. J. Thomson, F. Williamson and D. Grahn, Life shortening in mice exposed to fission neutrons and γ rays. VI. Studies with the white-footed mouse, Peromyscus leucopus. Radiat. Res. 108, 176-188 (1986).
39. E. Lorenz, J. Hollcroft, E. Miller, C. Congdon and R. Schweisthal, Long-term effects of acute and chronic irradiation in mice. I. Survival and tumor incidence following chronic irradiation of 0.11 r per day. J. Natl. Cancer Inst. 15, 1049-1058 (1956).
40. A. Caratero, M. Courtade, L. Bonnet, H. Planel and C. Caratero, Effect of a continuous gamma irradiation at a very low dose on the life span of mice. Gerontology 44, 272-276 (1998).
41. S. Tanaka, I. Tanaka, S. Sasagawa, K. Ichinohe, T. Takabatake, S. Matsushita, T. Matsumoto, H. Otsu and F. Sata, No lengthening of life span in mice continuously exposed to gamma rays at very low dose rates. Radiat. Res. 160, 376-379 (2003).
42. S. Benjamin, A. Lee, G. Angleton, W. Saunders, T. Keefe and C. Mallinckrodt, Mortality in beagles irradiated during prenatal and postnatal development. II. Contribution of benign and malignant neoplasia. Radiat. Res. 150, 330-348 (1998).
43. S. Gillette, E. Gillette, B. Powers and S. Withrow, Radiation-induced osteosarcoma in dogs after external beam or intraoperative radiation therapy. Cancer Res. 50, 54-57 (1990).
44. P. Johnstone, W. Laskin, A. DeLuca, M. Barnes, T. Kinsella and W. Sindelar, Tumors in dogs exposed to experimental intraoperative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 34, 853-857 (1996).
45. J. Broerse, R. Bartstra, D. van Bekkum, M. van der Hage, C. Zurcher, M. van Zwieten and C. Hollander, The carcinogenic risk of high dose total body irradiation in non-human primates. Radiother. Oncol. 54, 247-253 (2000).
46. C. Hollander, C. Zurcher and J. Broerse, Tumorigenesis in high-dose total body irradiated rhesus monkeys-A life span study. Toxicol. Pathol. 31, 209-213 (2003).
47. D. Wood, Long-term mortality and cancer risk in irradiated Rhesus monkeys. Radiat. Res. 126, 132-140 (1991).
48. M. Yochmowitz, D. Wood and Y. Salmon, Seventeen-year mortality experience of proton radiation in Macaca mulatta. Radiat. Res. 102, 14-34 (1985).
49. R. Miller, S. Marino, J. Napoli, H. Shah, E. Halle, C. Geard and D. Brenner, Oncogenic transformation in C3H10T 1/2 cells by low-energy neutrons. Int. J. Radiat. Biol. 76, 327-333 (2000).
50. D. Wood, A. Cox, K. Hardy, Y. Salmon and R. Trotter, Head and neck tumors after energetic proton irradiation in rats. Adv. Space Res. 14, 681-684 (1994).
51. R. Lonser, S. Walbridge, A. Vortmeyer, A. Pack, T. Nguyen, N. Gogate, J. Olson, A. Arkabasak, R. Bobo and E. Oldfield, Induction of glioblastoma multiforme in nonhuman primates after therapeutic doses of fractionated whole-brain radiation therapy. J. Neurosurg. 97, 1378-1389 (2002).
52. A. Upton, Radiation hormesis, data and interpretations. Crit. Rev. Toxicol. 31, 681-695 (2001).
53. E. Calabrese and L. Baldwin, The effects of gamma rays on longevity. Biogerontology 1, 309-319 (2000).
54. E. Calabrese and L. Baldwin, The hormetic dose-response model is more common that the threshold model in toxicology. Toxicol. Sci. 71, 246-250 (2003).
55. J. Kaiser, Hormesis: Sipping from a poisoned chalice. Science 302, 377-379 (2003).
56. R. Renner, Hormesis. Nietzsche's toxicology. Sci. Am. 289, 28-30 (2003).
57. E. Hall, The crooked shall be made straight; dose-response relationships for carcinogenesis. Int. J. Radiat. Oncol. Biol. Phys. 80, 327-337 (2004).
58. L. Feinendegen, Evidence for beneficial low level radiation effects and radiation hormesis. Br. J. Radiat. 78, 3-7 (2005).
59. A. Jemal, T. Murray, A. Samuels, A. Ghafoor, E. Ward and M. Thun, Cancer statistics, 2003. CA Cancer J. Clin. 53, 5-26 (2003).
60. D. A. Pierce and D. L. Preston, Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat. Res. 154, 178-186 (2000).
61. W. Heidenreich, H. Paretzke and P. Jacob, No evidence for increased tumor rates below 200 mSv in the atomic bomb survivors data. Radiat. Environ. Biophys. 36, 205-207 (1997).
62. D. Pierce and D. Preston, On, 'No evidence for increased tumor rates 200 mSv in the atomic bomb survivors' data.' Radiat. Environ. Biophys. 36, 209-210 (1997).
63. J. Cologne and D. L. Preston, Longevity of atomic-bomb survivors. Lancet 356, 303-307 (2000).
64. R. Kleinerman, J. Boice, H. Storm, P. Sparen, A. Andersen, E. Pukkala, C. Lynch, B. Hankey and J. Flannery, Second primary cancer after treatment for cervical cancer. An International Cancer Registries Study. Cancer 76, 442-452 (1995).
65. H. Storm, Second primary cancer treatment for cervical cancer. Cancer 61, 679-688 (1988).
66. T. Arai, T. Nakano, K. Fukuhisa, T. Kasamatsu, R. Tsunematsu, K. Masubuchi, K. Yamauchi, T. Hamada, T. Fukuda and H. Noguchi, Second cancer after radiation therapy for cancer of the uterine cervix. Cancer 67, 398-405 (1991).
67. D. Brenner, R. Curtis, E. Hall and E. Ron, Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 88, 398-406 (2000).
68. T. Pickles and N. Phillips, The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984-2000. Radiother. Oncol. 65, 145-151 (2002).
69. L. Travis, R. Curtis, H. Storm, P. Hall, E. Holowaty, F. van Leeuwen, B. Kohler, E. Pukkala, C. Lynch and J. Boice, Risk of second malignant neoplasms among long-term survivors of testicular cancer. J. Natl. Cancer Inst. 89, 1429-1439 (1997).
70. Z. Carr, R. Kleinerman, M. Stovall, R. Weinstock, M. Griem and C. Land, Malignant neoplasms after radiation therapy for peptic ulcer. Radiat. Res. 157, 668-677 (2002).
71. H. Weiss, S. Darby and R. Doll, Cancer mortality following x-ray treatment for ankylosing spondylitis. Int. J. Cancer 59, 327-338 (1994).
72. E. Radford, R. Doll and P. Smith, Mortality among patients with ankylosing spondylitis not given X-ray therapy. N. Engl. J. Med. 297, 572-576 (1977).
73. S. Darby, G. Reeves, T. Key, R. Doll and M. Stovall, Mortality in a cohort of women given x-ray therapy for metropathia haemorrhagica. Int. J. Cancer 56, 793-801 (1994).
74. A. Neugut, H. Ahsan, E. Robinson and R. Ennis, Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma. Cancer 79, 1600-1604 (1997).
75. G. Zagars, M. Ballo, A. Lee and S. Strom, Mortality after cure of testicular seminoma. J. Clin. Oncol. 22, 585-588 (2004).
76. D. Preston, A. Mattsson and E. Holmberg, Radiation effects on breast cancer risk: A pooled analysis of eight cohorts. Radiat. Res. 158, 220-235 (2002).
77. E. Obedian, D. Fischer and B. Haffty, Second malignancies after treatment of early-stage breast cancer: Lumpectomy and radiation therapy versus mastectomy. J. Clin. Oncol. 18, 2406-2412 (2000).
78. B. Fisher, S. Anderson, J. Bryant, R. Margolese, M. Deutsch, E. Fisher, J. Jeong and N. Wolmark, Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N. Engl. J. Med. 347, 1233-1241 (2002).
79. U. Veronesi, N. Cascinelli, L. Mariani, M. Greco, R. Saccozzi, A. Luini, M. Aguilar and E. Marubini, Twenty year follow up of a randomized study comparing breast conserving surgery with radical mastectomy for early breast cancer. N. Engl. J. Med. 347, 1227-1232 (2002).
80. M. Poggi, D. Danforth, L. Sciuto, S. Smith, S. Steinberg, D. Liewehr, C. Menard, M. Lippman, A. Lichter and R. Altemus, Eighteen year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute randomized trial. Cancer 98, 697-702 (2003).
81. X. Gao, S. Fisher and B. Emami, Risk of second primary cancer in contralateral breast in women treated for early stage breast cancer, a population-based study. Int. J. Radiat. Oncol. Biol. Phys. 56, 1038-1045 (2003).
82. L. Travis, D. Hill, G. Dores, M. Gospodarowicz, F. van Leeuwen, E. Holowaty, B. Glimelius, M. Andersson, T. Wiklund and E. Gilbert, Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin's disease. J. Am. Med. Assoc. 290, 465-475 (2003).
83. C. Rubino, A. Shamsaldin, M. Le, M. Labbe, J. Guinebretiere, J. Chavaudra and F. Vathaire, Radiation dose and risk of soft tissue and bone after breast cancer treatment. Breast Cancer Res. Treat. 89, 277-288 (2005).
84. Y. Kirova, J. Vilcoq, B. Asselain, X. Sastre-Garau and A. Fourquet, Radiation-induced sarcomas after radiotherapy for breast carcinoma. Cancer 104, 856-863 (2005).
85. J. Huang and W. Mackillop, Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer 92, 172-180 (2001).
86. E. Gilbert, M. Stovall, M. Gospodarowicz, F. van Leeuwen, A. Andersen, B. Glimelius, T. Joensuu, C. Lynch, R. Curtis and L. Travis, Lung cancer after treatment of Hodgkin's disease: Focus on radiation effects. Radiat. Res. 159, 161-173 (2003).
87. S. Hancock and R. Hoppe, Long-term complications of treatment and causes of mortality after Hodgkin's disease. Semin. Radiat. Oncol. 6, 225-242 (1996).
88. M. Deutsch, S. Land, M. Begovic, H. Wieland and B. Fisher, The incidence of lung carcinoma after surgery for breast cancer with and without post-operative radiotherapy. Cancer 98, 1362-1368 (2003).
89. L. Zablotska and A. Neugut, Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma. Cancer 97, 1404-1411 (2003).
90. E. Halperin, L. Constine, N. Tarbell and L. Kun, Secondary tumors. In Pediatric Radiation Oncology, pp. 538-562. Lippincott Williams & Wilkins, Philadelphia, 1999.
91. E. Ron, B. Modan, D. Preston, E. Alfandary, M. Stovall and J. Boice, Radiation-induced skin carcinomas of the head and neck. Radiat. Res. 125, 318-325 (1991).
92. E. Ron, B. Modan, J. Boice, E. Alfandary, M. Stovall, A. Chetrit and L. Katz, Tumors of the brain and nervous system after radiotherapy in childhood. N. Engl. J. Med. 319, 1033-1039 (1988).
93. J. Kuttesch, L. Wexler, R. Marcus, D. Fairclough, L. Weaver-McClure, M. White, L. Mao, T. Delaney, C. Pratt and L. Kun, Second malignancies after Ewing's sarcoma: Radiation dose-dependency of secondary sarcomas. J. Clin. Oncol. 14, 2818-2825 (1996).
94. A. Sigurdson, M. Doody, R. Rao, D. Freedman, B. Alexander, M. Hauptmann, A. Mohan, S. Yoshinaga, D. Hill and M. Linet, Cancer incidence in the U.S. Radiologic Technologists Health Study, 1983-1998. Cancer 97, 3080-3089 (2003).
95. A. Berrington, S. Darby, H. Weiss and R. Doll, 100 years of observation on British radiologists: Mortality from cancer and other causes 1897-1997. Br. J. Radiol. 74, 507-519 (2001).
96. G. Matanoski, A. Sternberg and E. Elliott, Does radiation exposure produce a protective effect among radiologists? Health Phys. 52, 637-643 (1987).
97. D. Brenner and E. Hall, Mortality patterns in British and U.S. radiologists: what can we really conclude? Br. J. Radiol. 76, 1-2 (2003).
98. E. Cardis, M. Vrijheid, M. Blettner, E. Gilbert, M. Hakama, C. Hill, G. Howe, J. Kaldor, C. R. Muirhead and K. Veress, Risk of cancer after low doses of ionising radiation: Retrospective cohort study in 15 countries. Br. Med. J. 331, 77 (2005).
99. D. Brenner, R. Doll, D. Goodhead, E. Hall, J. Little, J. Lubin, D. Pierce, R. Preston, J. Puskin and M. Zaider, Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know. Proc. Natl. Acad. Sci. USA 100, 13761-13766 (2003).
100. National Research Council, Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, Health Risks from Exposure to Low Levels of Ionizing Radiation. BEIR VII Phase 2. National Academies Press, Washington, DC, 2005.
101. A. Aurengo, D. Averbeck, A. Bonnin, B. LeGuen, R. Masse, R. Monier, M. Tubiana, A-J. Valleron and F. de Vathaire, Dose-Effect Relationships and Estimation of the Carcinogenic Effects of Low Doses of Ionizing Radiation. The French National Academy of Medicine, Paris, 2005.
102. A. Taghian, F. deVathaire, P. Terreir, A. Auquier, H. Mouriesse, E. Grimaud, D. Sarrazin and M. Tubiana, Long-term risk of sarcoma following radiation treatment for breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 21, 361-367 (1991).
103. T. Davidson, G. Westbury and C. Harmer. Radiation-induced soft tissue sarcoma. Br. J. Surg. 73, 308-309 (1986).
104. R. Curtis, P. Rowlings, H. Deeg, D. Shriner, G. Socie, L. Travis, M. Horowitz, R. Witherspoon, R. Hoover and J. Boice, Solid cancers after bone marrow transplantation. N. Engl. J. Med. 336, 897-904 (1997).
105. J. Loeffler, A. Niermierk and P. Chapman, Second tumor after radiosurgery: Tip of the iceberg or a bump in the road? Neurosurgery 52, 1436-1442 (2003).
106. M. Brada, D. Ford, S. Ashley, J. Bliss, S. Crowley, M. Mason, B. Rajan and D. Traish, Risk of second tumor after conservative surgery and radiotherapy for pituitary adenoma. Br. Med. J. 304, 1343-1346 (1992).
107. D. Grahn, R. J. M. Fry and R. Lea, Analysis of survival and cause of death statistics for mice under single and duration-of-life gamma irradiation. Life Sci. Space Res. 10, 175-86 (1972).
108. R. L. Ullrich, M. Jernigan, L. Satterfield and N. Bowles, Radiation carcinogenesis: Time-dose relationships. Radiat. Res. 111, 179-184 (1987).
109. R. L. Ullrich, Effects of split doses of in vivo rays or neutrons on lung tumor formation in RFM mice. Radiat. Res. 83, 138-145 (1980).
110. D. Brenner and E. Hall, Commentary 2 to Cox and Little: Radiation-induced oncogenic transformation: The interplay between dose, dose protraction, and radiation quality. Adv. Radiat. Biol. 16, 167-179 (1992).
111. B. Carnes, D. Grahn and D. Hoel, Mortality of atomic bomb survivors predicted from laboratory animals. Radiat. Res. 160, 159-167 (2003).
112. NCRP, Extrapolation of Radiation-Induced Cancer Risks from Non-human Experimental Systems to Humans. Report No. 150, National Council on Radiation Protection and Measurements, Bethesda, MD, 2005.